EI
Estrella Immunopharma Inc.
🇺🇸XNAS.ESLAWUnited StatesHealthcare
$0.07USDdown -0.01 (-12.5%)ClosedDelayed11:32 PM
Price$0.07-0.01 (-12.5%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US2975841048
- CUSIP
- Not reported
Company
- Employees
- 0
- Headquarters
- EmeryVille, United States
- Website
- https://www.estrellabio.com
- CEO
- Dr. Cheng Liu Ph.D.
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- -$0.23
- P/E LTM
- -4.47
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$10.01M+17.09%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$9.38M-134.92%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.